Clinical Trials
2 trialsNCT06030622 2024-04-19
C3
State University of New York - Downstate Medical Center
Phase 1/2 Unknown
NCT00960115 2015-10-21
Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy
Merck KGaA, Darmstadt, Germany
Phase 1/2 Completed